Source: Health Canada shortage reports · Updated Jul 22, 2026
Scopolamine is in a widespread shortage in Canada. 2 of 4 reported products are affected. The latest manufacturer estimate for full recovery is Aug 14, 2026.
An anticholinergic used to prevent motion sickness and nausea.
Products affected
2 / 4
In shortage since
May 1, 2026
Est. full return
Aug 14, 2026
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · since Jul 20, 2026, est. end Aug 14, 2026 · Demand increase for the drug.
Active shortage
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · since May 1, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · ended Feb 27, 2026 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · ended Jan 30, 2026 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · ended Feb 28, 2024 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · ended Feb 19, 2024 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · ended Nov 2, 2023 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · ended Mar 10, 2023 · Demand increase for the drug.
Avoided
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · ended Feb 24, 2023 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.4MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242810 · ended Dec 20, 2022 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · ended Dec 1, 2022 · Demand increase for the drug.
Resolved
SCOPOLAMINE HYDROBROMIDE INJECTION
0.6MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02242811 · ended Mar 11, 2022 · Demand increase for the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Scopolamine is currently affected by 2 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Scopolamine is classified under “HYPNOTICS AND SEDATIVES” (ATC N05CM).
Recent changes
Jul 22, 2026
New report filed
Common questions
What is Scopolamine used for?
An anticholinergic used to prevent motion sickness and nausea.
When will Scopolamine be back in stock in Canada?
The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Scopolamine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.